Journal Home
Search for

Volume 50, Issue 4, Pages 693-704 (April 2009)


View previous. 18 of 38 View next.

Acute infection with a single hepatitis C virus strain in dialysis patients: Analysis of adaptive immune response and viral variability

Lukas Weseslindtner1, Christoph Neumann-Haefelin2, Sergei Viazov3, Anita Haberstroh2, Josef Kletzmayr4, Judith H. Aberle1, Joerg Timm3, Stefan R. Ross3, Renate Klauser-Braun4, Thomas F. Baumert25, Michael Roggendorf3, Robert Thimme2, Heidemarie Holzmann1Corresponding Author Informationemail address

Received 3 September 2008; received in revised form 6 November 2008; accepted 24 November 2008. published online 27 January 2009.

Background/Aims

While the adaptive immune response is crucial for spontaneous resolution of acute hepatitis C virus (HCV) infection, it also constitutes the driving force for viral escape. For acutely HCV-infected dialysis patients, little is known about the host response and its impact on viral evolution.

Methods

Four haemodialysis patients accidentally infected with the same HCV strain were prospectively investigated with respect to the clinical course, CD4+ and CD8+ T-cell responses, neutralizing antibodies, viral kinetics and sequence variability.

Results

In one patient, a robust CD4+ T-cell response was associated with transient control of infection, while in the other patients, weak responses correlated with persistently high viremia. Despite the presence of CD8+ T-cell effectors in the first patient, no sequence differences were detected in targeted regions of the viral genome in any of the patients when viral persistence was established. Genetic stability in the envelope genes, including the hypervariable regions, correlated with low-level or absent neutralizing antibodies in all of the patients.

Conclusions

The establishment of viral persistence in the special patient group of dialysis patients is due to a failure of the adaptive immune system, as shown by the absence of significant T-cell and antibody responses, as well as viral variability.

Associate Editor: V. Barnaba

1 Clinical Institute of Virology, Medical University of Vienna, Kinderspitalgasse 15, A-1095 Vienna, Austria

2 Department of Medicine II, University Freiburg, Freiburg, Germany

3 Institute of Virology, Essen University Hospital, Essen, Germany

4 Department of Medicine III, Danube Hospital, Vienna, Austria

5 INSERM Unite 748, Universite Louis Pasteur, Strasbourg, France

Corresponding Author InformationCorresponding author. Tel.: +43 1 40 490 79522; fax: +43 1 40 490 97 95.

 The authors declare that they do not have anything to disclose regarding funding from industries or conflict of interest with respect to this manuscript. The underlying research reported in the study was funded by the “Hochschuljubiläumsstiftung” of the city of Vienna, Austria (Project H1802/2006).

PII: S0168-8278(09)00006-3

doi:10.1016/j.jhep.2008.11.023


View previous. 18 of 38 View next.